ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Guidelines Published On Lung Cancer Treatment

February 28, 2003

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005